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Introduction: A systematic literature review was conducted to identify key predictors of
poor adult retention in HIV medical care in developed and developing countries.
Methods: An electronic search was conducted with MEDLINE (OVID), PubMED,
EBSCO, SCOPUS, and Cochrane databases, as well as manual searches. Inclusion
and exclusion criteria were decided, and only original quantitative studies which
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Results and discussion: Of the two hundred and sixty-eight articles identified, twenty
six were included in the review following an independent assessment by two raters.  In
developed countries, the most frequently cited predictor of poor retention in care was
active substance use. In developing countries, demographic and medical factors were
the most frequently cited factors associated with poor retention in care.
Conclusions: Psychosocial factors are important considerations when targeting
interventions to improve retention rates. This review compares the results for
developed versus developing countries, and suggests primary concerns for poor
retention include substance use, demographic and medical factors.




Introduction: A systematic literature review was conducted to identify key predictors of poor adult 
retention in HIV medical care in developed and developing countries. 
 
Methods: An electronic search was conducted with MEDLINE (OVID), PubMED, EBSCO, SCOPUS, and 
Cochrane databases, as well as manual searches. Inclusion and exclusion criteria were decided, and 
only original quantitative studies which identified predictors of retention in care were reported on. 
 
Results and discussion: Of the two hundred and sixty-eight articles identified, twenty six were 
included in the review following an independent assessment by two raters.  In developed countries, 
the most frequently cited predictor of poor retention in care was active substance use. In developing 
countries, demographic and medical factors were the most frequently cited factors associated with 
poor retention in care. 
 
Conclusions: Psychosocial factors are important considerations when targeting interventions to 
improve retention rates. This review compares the results for developed versus developing 
countries, and suggests primary concerns for poor retention include substance use, demographic 
and medical factors.  
 











































































The Human Immunodeficiency Virus (HIV) Care and Treatment Cascade outlines the proportion of 
people living with HIV (PLWHIV) across a number of domains: living with HIV, linked to/engaged in 
care, retained in care, on treatment, and virologically suppressed [1]. The Centres for Disease 
Control and prevention [2] in the US estimates only 50% of PLWHIV receive regular medical care, 
compared to an estimate of 73% in Australia [3]. The World Health Organization (WHO) estimates 
that most PLWHIV are lost to follow up (LTFU) within the first few years of starting treatment. Their 
synthesis of the available data suggests that the average retention rate 12 months after initiating 
medication ranges from 64% to 94%, and can reach 60% at 60 months in resource-limited countries 
[1]. In the interest of providing holistic HIV care, understanding the role of psychosocial factors in 
managing engagement with and retention in medical care is important. 
 
Since their inception in the 1990’s, significant improvements have been made to Antiretroviral 
Therapy (ART), and subsequently developed Highly Active Antiretroviral Therapy (HAART), with 
respect to efficacy, dosage and how well they are tolerated. In developed countries HAART is widely 
available, in contrast to resource-limited countries where there are significantly fewer medication 
options. Early findings from a recent clinical trial, the Strategic Timing of AntiRetroviral Treatment 
(START), across 35 countries indicate that starting medication early and maintaining adherence is 
beneficial from an individual health perspective [4]. Maintaining medication adherence affords 
optimal suppression of the virus and ensures a functioning immune system, leaving individuals less 
vulnerable to other infections/illnesses. Recent evidence also points to a strong link between 
virological suppression and a decrease in the risk of HIV transmission [5], which is the basis for the 
WHO global public health initiative ‘Treatment as Prevention’ [1]. Thus, retaining HIV+ individuals in 
medical treatment/care to increase HAART adherence is key in the maintenance of individual health 





































































Multiple HIV treatment guidelines address adherence to treatment and retention in HIV care. The US 
Department of Health and Human Services recommends those who are newly diagnosed with HIV 
should immediately commence HAART, access medical care every three to four months, and 
continue this regime until they are virologically suppressed [6]. The US Health Resources and 
Services Administration (HRSA) defines successful retention in medical care as at least two visits 
(including blood collection to determine viral load) in a calendar year, spaced at least three months 
apart [6, 7]. This guideline is consistent with the European AIDS Clinical Society Guidelines [8]. More 
broadly, the WHO [1] has globally recommended that those who are stable on medication to be 
reviewed clinically every 3-6 months.  
 
While the topic of retention in care has been broadly studied and reviewed, there lacks a synthesis 
of the literature to date to assist researchers and clinicians to identify and understand the key 
predictors of poor retention in HIV care. The overarching goal, regardless of country or resources 
available, is to improve adherence to medication to benefit both the individual and the wider public. 
The optimal way to achieve this is by retaining patients in care in order to address medical and 
psychological comorbidities, medication adherence, and other psychosocial factors which impact 
upon physical and mental health.  In this way, developing our understanding of the key factors which 













































































Systematic literature search 
Search terms and associated synonyms reflecting predictors of retention in care for HIV+ populations 
were identified. Synonyms were identified for key themes of interest, and five databases (MEDLINE 
[OVID], PubMED, EBSCO, SCOPUS, and Cochrane) were searched using the following terms: (predict* 
OR factor* OR caus* OR Component* OR Correlat*) – Title, AND (retention* OR retain* OR engage* 
OR continuum OR treatment cascade) – Title, AND (HIV) – keyword. Manual searches through 
reference lists of relevant articles were also conducted. Duplicates were deleted, and articles were 
then screened by title, abstract and article content by two authors (SB and TNJ), with articles not 
meeting the agreed upon criteria removed. Figure 1 shows the Preferred Reporting Items for 




Searches were limited to adult populations, published articles post-1995 (to identify those written in 
the medication era), and those in English. Articles related to medication adherence, focusing on 
linkage as opposed to retention in care, and focusing on measuring retention or interventions to 
improve retention were all excluded from the analysis. Specific samples based on systemic factors 
which may impact results were also excluded; for example, forensic populations where clients were 
mandated to attend appointments. Articles relating to a range of adult populations were included, 
on the basis that they could offer insight into retention issues from a broader context. 
 
Original quantitative articles only (retrospective and prospective studies) were included while 
reviews were not, and studies which focused on psychosocial, demographic, medical and welfare 
issues were included to provide a breadth of knowledge and understanding regarding all possible 





































































Study appraisal and selection 
The inclusion/exclusion criteria were defined by SB and TNJ. The first 10 articles were jointly 
reviewed to establish consistency, with the following 96 reviewed separately and then compared. 
Inter-rater reliability of 89.6% was achieved and, through consultation, agreement was reached 
regarding the remaining articles. In this context, the semantics associated with articles required clear 
definition, such that both raters were certain about the differences between articles focusing on 
access vs. linkage vs. engagement vs. retention to/in care. A total of 26 articles were included in the 
review (see Figure 1). 
 
Data extraction and review 
Data were extracted from the articles by the primary author (SB) using the PRISMA-P protocol. This 
standardised method of extracting data obtained information regarding the quality of the study 
(appropriate use of measures and analyses, internal and external validity, any ethical concerns, 
minimisation of any bias), and confirmed the research met the inclusion criteria agreed upon by SB 















































































The database and manual searches yielded a total of 268 articles, with 26 retained for final review 
(see Figure 1 for a full appraisal of the article selection process). Of the 26 remaining, all listed 
retention in care as a dependent/outcome variable. One study [10] operationalized retention in care 
as the duration of episodes on or off HARRT as defined by pharmacy dispensing records. While this is 
associated with medication, it does not relate to adherence per se but instead explores medication 
dispensing which is consistent with other measures of retention. In most other studies, attendance 
to medical appointments, including phlebotomy, was used to measure retention in care.  
 
There were stark differences between the predictors identified for developing versus developed 
countries, which speaks to inherent access differences and different priorities; developed countries 
offer comparatively greater access to medical care than their developing counterparts. Table I 
provides a broad overview of the studies retained for analysis, including the setting, design, 
participants and primary outcomes (predictors of retention identified). Table II and Table III identify 
the predictors for developed and developing countries respectively. There were fifteen articles 
which focused on developed countries, and eleven which targeted developing countries, as defined 
by the United Nations World Economic Situation and Prospects [11]. The predictors of retention in 
care have been categorised under the broad banners of developed and developing countries, and 
are presented from higher to lower frequency in the articles included in the review. Results are also 












































































Substance use was, by far, the most cited predictor of poor retention in the literature in developed 
nations, and was referred to in 50% of the studies examined. [12] theorised a model of predisposing 
and needs factors in a sample of detainees recently released from jail, but not mandated to attend 
HIV treatment. This study used viral load (VL) testing as a proxy for retention in care, a practice used 
by other researchers in this field. They also utilised the Behavioural Model for Vulnerable 
Populations to suggest that predisposing (for example, demographics, mental health, substance use) 
and needs factors (including medical comorbidity, addiction severity and psychiatric severity) 
interact with other factors (for example, jail and community services) to influence health behaviours; 
in this instance, medication adherence and retention in care. Using logistic regression, the authors 
concluded that substance use, among other factors, was significantly associated with poorer 
sustained retention in care. 
 
Other studies which identified a relationship between active substance use and poor retention 
include [13], who reviewed a cohort of US Veterans; [14], who reported the greatest attrition rate 
from medical care among their substance using population above all others; [10], who noted that 
intravenous drug use (IVDU) in particular was associated with poor retention; [15], who noted that 
those within the IVDU HIV transmission risk group were more likely, than their non-IVDU 
counterparts, to dropout of care; and [16], who identified that those classified as receiving “no care” 
(i.e. those who did not see a doctor for their HIV after diagnosis, or had not seen an HIV specialist 








































































Psychiatric Co-Morbidities  
Psychiatric illness, besides substance use, has been identified in a number of the studies reviewed as 
being a significant predictor of poor retention in care. [16] noted that subjects with poorer mental 
health scores were less likely to be retained in care. [17] further noted that active psychiatric illness 
at the last clinical visit was associated with not returning for care. Conversely, [18] noted in their 
study that those who reported at least 14 “mentally unhealthy” days per month were more likely to 
remain retained in care. 
 
Demographics 
Various demographic characteristics were also identified as strong predictors of retention in care. 
Those factors associated with poorer retention in care included male sex [19], female sex [10, 12, 14, 
15], having young children [18], younger age [10, 13, 14, 19, 20], and being from an ethnic minority 
[15, 18]. [10] further identified aboriginality was a predictor of poor retention in their Canadian 
study. Conversely, [19] found that certain ethnic minorities (e.g. Latinos) were more likely to be 
retained than others (e.g. African Americans, or Anglo Americans). 
 
HIV-Disease Progression and Medical Co-Morbidities 
Some authors identified that medical, rather than psychosocial, factors were pertinent to a person’s 
capacity to remain engaged in care. [13] identified that those with Hepatitis C (HCV) coinfection and 
with higher CD4 counts (>350 x 106/L) were less likely to be retained in care. Those with HCV 
coinfection were also more likely to present with active substance use, which would likely have 
further interfered in retention. It is possible that a higher CD4 count is also related to health beliefs 
(e.g. “feeling well”) and therefore a perception of not requiring medical care [10, 20]. Conversely, [7] 







































































In their study of retention among a US cohort of women of colour, [18] identified that those who 
had dependent children <18 years old and those living in institutional facilities were less likely to 
remain retained in care. [7] noted that patients who were publicly insured were less likely to be 
retained in care. [21] also identified that cost (e.g. lack of insurance) was a significant barrier to them 
continuously accessing care despite, as the authors noted, the study being conducted in a US state 
with universal access to care.  
 
Miscellaneous (health beliefs, support, domestic violence, practical factors) 
Other factors have also been identified as predictors of poor retention in care. Health beliefs appear 
to play an important role, and include feeling hopeless about treatment for HIV [18]; feeling well and 
being too busy [17]; perceiving ‘wellness’ as a barrier to seeking treatment, not trusting the medical 
system or not ‘bothering’ because there is no cure [16]. In addition, [22] identified that intimate 
partner violence could have a role, such that patients who feel threatened by their partner are less 
likely to remain retained in care. 
 
Practical factors (e.g. access to transport to attend appointments, ease of obtaining an appointment 
with an HIV specialist) were also identified as barriers to patients remaining in care [21]. These 
authors found that this was more of an obstacle than other psychosocial issues such as depression 
and substance use, despite these being highly prevalent.  
 
Predictors of Retention 
Even though most studies have focused on barriers to retention, some have focused on predictors to 
retention in care. A number of authors have also looked at the role of certain factors in improving 
retention rates; for example, social and/or professional support. [16] noted that professional 




































































greater retention in care. [12] also noted that access to case management was an important factor 
to improve retention in their population of recently released inmates. [23] also identified that social 
support mediates the relationship between cognitive impairment and retention in care, such that 
those who are cognitively impaired and have some support are more likely to be retained in care. 
Conversely, [24] noted in their study of newly diagnosed patients that social support did not 




Demographic factors were identified in eight of the 11 articles which focused on resource-limited 
countries, suggesting it is a key predictor of poor retention in developing populations. Factors such 
as sex, age, and education level were frequently cited in these articles. For example, a number of 
articles noted that male sex was associated with an increased risk of attrition from care [25-29], as 
was younger age [30, 31], and lower levels of education [26, 32, 33]. 
 
HIV-Disease Progression and Medical Co-Morbidities 
HIV-disease progression [26-31, 33], and lower body mass index (BMI) [25, 27, 28, 31, 34] were also 
cited in eight of the 11 articles in developing countries. Lower baseline CD4 counts or higher WHO 
stage of the disease was usually associated with higher rates of attrition, however in a number of 
articles, the authors noted that higher CD4 counts were related to poorer retention in care [30, 33]. 
[31] found that those with a poorer level of functionality (e.g. those who were bedridden) were also 
less likely to remain retained in medical care. [26] also noted that those with either low or high 
baseline CD4 counts were more likely to be lost to follow-up (LTFU). It is possible that, for some 
people, having the health belief of “feeling well”, as well as “feeling unwell” for others, is a risk 





































































Miscellaneous (Process/Clinic Factors, Mental Health) 
Other factors associated with poor retention in care were cited far less frequently than those already 
mentioned in the literature reviewed in resource-limited countries. [30] notes that those patient 
who commenced medication as an inpatient or when pregnant were at greater risk of LTFU. The 
authors suggest this may be because patients were required to commence medication at a faster 
rate than usual, and perhaps before they were psychologically ready, thereby limiting their capacity 
to effectively prepare for it. [32] also noted that patients who had not received medication 
adherence counseling at baseline were less likely to remain engaged in regular medical care, and 
that those who commenced medication later in the study period were more likely to become LTFU. 
This finding was replicated by [34], and likewise [31] found that retention rates decreased as the 
number of years the clinic had been in operation increased. [32] suggested this may be due to 
increased workload within the clinic in the absence of any increase in resources. Likewise, [29] noted 
that clinics with part-time (compared to full-time) nursing and medical staff demonstrated poorer 
retention rates. [27] also note that those initiating medication at primary healthcare facilities 
(compared to district hospitals) were more likely to remain retained, and the authors suggest this is 
likely because rural patients would travel to urban hospitals to initiate treatment under medical 
specialists and then likely transfer back to rural facilities. 
Only one study in developing countries included in the review investigated the potential role of 
mental health, and found that mental health concerns were a factor in retention rates in developing 
countries. [35] found that depression was significantly associated with LTFU rates, and that this 










































































The 26 articles included in this systematic review highlight both the complexity of the issues 
surrounding retention in care, and the paucity of knowledge regarding consistent factors which 
reliably predict it. The differences associated with retention rates, and the factors with which they 
are related, between developed and developing countries is also evident. This issue is not unique to 
HIV and is well documented throughout the chronic disease literature; however there are factors 
specific to the HIV+ population which require particular attention.  
 
The primary predictor of poor retention identified in developed countries in this review is active 
substance use [10, 12-16]. We already know that active substance use impacts the frontal cortex, 
among other structures, which is responsible for a person’s capacity to plan and make decisions [36]. 
The limbic system (the ‘reward center’) is also implicated in substance use, meaning intoxicated 
individuals not only experience a heightened sense of reward and pleasure, but also potentially lack 
the capacity to effectively care for themselves in the short, medium and long-term, depending on 
the severity of their use [36]. Disorganisation, impulsivity, lack of stable housing, and other medical 
and social problems associated with substance use are also likely to contribute to poor retention in 
care. In the context of retention, it is clear that treating substance use in order to alter the effects of 
substances on the brain could better equip a person to make decisions and manage their healthcare. 
Active substance use can also impact certain populations more than others. In many developed 
countries (for example, Australia) the prevalence of HIV in MSM populations is higher than the 
general population, and substance use is common within the community, in part due to its (often 
positive) impact on the frequency and intensity sexual experiences [37], as well as management of 
perceived stigma and potential discrimination [38]. Developing our knowledge about or treatment of 
substance use in this particular context may positively impact retention rates. A goal for future 
research might be to ascertain the level of variance accounted for by substance use in a regression 





































































Demographic factors were also highly predictive of retention rates in the literature surveyed, both in 
developed and resource-constrained countries. In particular, sex, age, education level and ethnicity 
all appear to play a large role in retention rates, across the board. Health beliefs such as self-
efficacy/locus of control were important, and may moderate relationships with other variables. For 
example, younger people may not fully appreciate the necessity for ongoing medical care or feel 
unable to ‘commit’; conversely, older people may feel as though there is “no point” in managing 
their care. Further research is required to explore these relationships. 
 
Medical factors, including how unwell a person was, were also highly correlated with retention in 
care. Studies identifying competing results have been reviewed here, such that some authors [7, 28] 
noted that those with lower baseline CD4 counts were less likely to be retained, while others [20, 
30] found the opposite to be true. It is evident that these mixed findings are apparent in both 
developed and developing countries. Clearly further research is warranted to explore these 
discrepancies, with a number of potentially influential factors including health beliefs, level of social 
support and other demographic variables requiring examination.  
 
Other key predictors of retention identified in this review were health beliefs, psychiatric illness, 
support, social/welfare issues, clinic factors, and others. The prevalence of psychiatric illness, 
especially mood disorders, in an HIV+ population is well documents [39], as is the impact this can 
have on self-care including attendance to medical appointments and medication adherence [35]. 
Health beliefs in particular appear to have strong correlations (e.g. feeling too well or too busy) [17]. 
In addition, professional support in the form of case management appeared to positively assist 
vulnerable populations (e.g. forensic) [12] to remain engaged in care. Other practical factors, 
including the ease with which patients can attend appointments [21], and clinic factors (e.g. the 




































































medication adherence counselling prior to initiation [32] were also noted. These point to the subtle 
interplay between psychological and social factors impacting retention, and acknowledge the role of 
both in researching this area. 
 
In resource-limited countries, compared to developed countries, it appears that fundamental factors 
such as weight, disease progression, and education level are the key factors which impact upon 
retention in care, whereas in developed countries other factors such as psychiatric illness and active 
substance use are the primary factors which interfere in optimal retention in care. This points to 
inherent differences between developed and developing countries with respect to access to 
adequate care and medication, and the overall differences between patient needs in both contexts. 
 
Of interest is the absence of quantification of the role of perceived stigma and/or discrimination in 
impacting an individual’s capacity or willingness to remain retained in medical HIV care. This is 
despite numerous findings regarding the importance of stigma and/or discrimination in HIV [e.g. 40], 
including its impact on self-efficacy and perceived capacity to manage one’s own health [41]. While 
attitudes and understanding about HIV and its transmission in developed countries have greatly 
improved over the past 30 years, stigma and/or discrimination regarding HIV remains an issue for 
some, and it was therefore expected to have been identified as a predictor. Despite this, none of the 
studies included in this review explicitly investigated the potential role of stigma in retention in care. 
Likewise, it was not identified as a retention-interfering factor in the developing countries literature, 
which is perhaps even more surprising. In their study, [27] noted that those HIV-infected patients in 
rural settings were more likely to travel to urban areas for their medical treatment, and it is possible 
this is related (at least in part) to concerns around stigma and/or discrimination.  
 
A large proportion of the studies included in this review employed a retrospective cohort design; this 




































































studies. An issue with retrospective studies is the risk that key variables are missed as the analysis 
depends wholly on data routinely collected (for example, it is unlikely that perceived stigma and/or 
discrimination would have been routinely collected). A further limitation is that many of the studies 
reviewed discuss correlates versus predictors of retention in care. It is possible this is an issue of 
semantics, where the terms are used interchangeably. It is also possible that some of the studies 
lacked the statistical design necessary to identify predictors as distinct from correlates. Future 
research could attempt to cohesively measure predictors of retention, for the purposes of 
identifying those ‘at-risk’ of dropping out and intervening as early as possible. 
 
A key issue with the data reviewed involves definitional terms; there appears to be a lack of 
consistency regarding the terminology in this area. For example, the terms ‘engagement in care’ and 
‘retention in care’ are often ill-defined and used interchangeably, and this impacted the search 
strategy and the analysis of the articles to ensure authors’ definition of retention in care matched 
our own. Likewise, definitions of retention in care varied slightly between studies, despite there 
being clear guidelines stipulated by the HRSA and EACS [7, 8] in developed countries. It seems there 
are no/limited guidelines specifically related to developing countries, which may in itself be an issue, 
in addition to the varied definitions of LTFU which were employed by studies. 
 
There are limitations with some of the specific studies reviewed, the most common of which relates 
to the definition and means of measuring retention in care. Inconsistencies were noted in the ways 
in which retention was measures; some used viral load tests as a proxy for retention [e.g. 12, 15], 
while others [e.g. 18] measured attendance to HIV medical appointments. [16] used self-reported 
use of medical services as the outcome variable in their analysis, perhaps not the most rigorous test 
of this variable and open to subjective bias. The definition of LTFU also needs to be carefully 




































































were counted as LTFU, suggesting their retention rates may be underestimated. A reliable way of 
measuring retention would likely be useful in standardising conclusions. 
 
Inherent in this investigation into predictors of retention is the necessity to focus/direct 
interventions appropriately so as to maximise retention rates. A thorough understanding of these 
factors is therefore necessary in order to fully achieve this goal. Furthermore, given the bulk of the 
literature in developed countries is from the US/Canada, it would be important to conduct studies in 
other developed countries to ascertain whether there are any differences, given the different nature 
of the epidemic across the globe, and fundamental differences in access to medical care and 
medication. There were no articles included from Europe, for example, which satisfied all eligibility 
criteria. This may point to a gap in our knowledge, or that HIV retention research in developed 
countries is concentrated on the United States and Canada.  
 
Conclusions 
As treatments improve we have an ageing HIV+ population, which is accompanied by an increase in 
comorbidities and amplifies the need for often complex monitoring and retention in care. 
Concentrating on medical aspects alone can fail to account for the broader range of factors which 
impact an individual’s life. In this way, expanding this focus to retention in HIV care (versus 
medication adherence alone) offers a more holistic view of HIV management and moves away from 
the pure medical model to account for psychological and physical comorbidities, and other 
psychosocial issues in conjunction with medication adherence.  
 
The literature reviewed here points to a collection of factors which appear to predict retention in 
medical HIV care, both across developed and developing countries. However, it is also clear that 
further research is required to quantify some of the constructs identified (e.g. stigma and/or 




































































have a sound knowledge regarding the factors that contribute to poor retention, little remains 
understood regarding the complexity of interrelationships between these, and whether intervening 
in one part of the system will ultimately impact the outcome. 
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Figure 1. PRISMA-P flowchart of article selection 
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106 articles screened 
26 articles included in 
systematic review 
190 articles remaining 
72 removed due to title, abstract and 
article: 
- HIV negative 
- sexual risk-taking/unsafe sex 
- medication adherence 
- Specific sample based on 
systemic factors 
- Not focussing on predictors 
- Focus on medication 
adherence 
- Focus on linkage to vs. 
retention in care 
- Focus on measures of 
retention 
- Focus on interventions 
 
78 removed: 
- Not adults 
- <1995  
- Non-English 
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Table I. Predictors of retention in HIV care – Developed and developing countries 
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Table II. Summary of predictors of retention in care, and associated articles – Developed Countries 
 
Predictor(s) of 
retention in care 
Number of articles in which 
predictor(s) is/are cited 
Referenced in [First author (year)] 
Substance use 7 Althoff (2013); Dombrowski (2015);  Giordano (2009);  Lourenço (2014);  Noysk (2015);  Rebeiro (2013);  Tobias (2007)   
Demographic 7 Althoff (2013); Blank (2015); Giordano (2009); Horberg (2015);  Noysk (2015);  Rebeiro (2013); Richey (2014) 
Medical 5 Blank (2015);  Giordano (2009); Noysk (2015);  Richey (2014); Tedaldi (2014) 
Mental health 4 Blank (2015); Dombrowski (2015);  McMahon (2015);  Tobias (2007) 
Support 4 Althoff (2013); Kelly (2014); Tobias (2007);  Waldrop-Valverde (2014) 
Health beliefs 3 Blank (2015); McMahon (2015);  Tobias (2007) 
Social/welfare 3 Blank (2015);  Rebeiro (2013);  Tedaldi (2014) 
Cognitive impairment 1 Waldrop-Valverde (2014) 
Domestic violence 1 Schafer (2012) 
Linkage to care 1 Richey (2014) 
Time 1 McMahon (2015) 
   
Table II. Summary of predictors of retention in care, and associated articles -
Developed Countries
Click here to download Table renamed_260e0.doc 
Table III. Summary of predictors of retention in care, and associated articles – Developing Countries 
 
Predictor(s) of 
retention in care 
Number of articles in which 
predictor(s) is/are cited 
Referenced in [First author (year)] 
Demographic 8 Allam (2014); Boyles (2011); Charurat (2010); Koole (2014); Mutasa-Apollo (2014); Thida (2014); Vella 
(2010); Vuylsteke (2015); Yang (2015) 
Medical 8 Allam (2014); Boyles (2011);  Charurat (2010);  Koole (2014);  Mutasa-Apollo (2014); Palombi (2009); Thida 
(2014); Vella (2010); Yang (2015) 
Process/Clinic Factors 4 Koole (2014); Mutasa-Apollo (2014); Vella (2010);  Vuylsteke (2015) 
Mental health 1 Krumme (2014) 
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